Shares of Nanosonics Limited (OTCMKTS:NNCSF – Get Free Report) dropped 1.8% during trading on Wednesday. The company traded as low as $2.00 and last traded at $2.00. Approximately 5,000 shares were traded during trading, an increase of 93% from the average daily volume of 2,597 shares. The stock had previously closed at $2.0360.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada upgraded shares of Nanosonics from a “sector perform” rating to an “outperform” rating in a research note on Tuesday, September 15th. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy”.
Get Our Latest Stock Report on NNCSF
Nanosonics Price Performance
Nanosonics Company Profile
Nanosonics Limited is an Australian medical technology company focused on infection prevention and control in healthcare settings. The company develops, manufactures and commercializes products designed to support the safe and effective reprocessing of medical instruments, with a particular emphasis on ultrasound procedures.
Its principal product family is the trophon system, which uses automated, high-level disinfection technology to reprocess ultrasound probes that cannot be safely disinfected through conventional methods.
Recommended Stories
- Five stocks we like better than Nanosonics
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Nanosonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosonics and related companies with MarketBeat.com's FREE daily email newsletter.
